Adamas Pharmaceuticals, Inc. announced that on December 7, 2015, Jeffrey Knapp, Chief Operating Officer, resigned effective January 29, 2016, for personal reasons. John MacPhee, a member of board of directors, will provide commercial advisory oversight on an interim basis until a Chief Commercial Officer is named.